{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:17:29Z","timestamp":1769599049729,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.prp.2022.153831","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T15:47:29Z","timestamp":1646668049000},"page":"153831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"232","author":[{"given":"Yue","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy Y.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.prp.2022.153831_bib1","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1128\/MCB.01031-06","article-title":"LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin","volume":"26","author":"Thyssen","year":"2006","journal-title":"Mol. Cell Biol."},{"issue":"46","key":"10.1016\/j.prp.2022.153831_bib2","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/sj.onc.1204866","article-title":"LAPSER1: a novel candidate tumor suppressor gene from 10q24.3","volume":"20","author":"Cabeza-Arvelaiz","year":"2001","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.prp.2022.153831_bib3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1096\/fj.06-7254com","article-title":"LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin","volume":"21","author":"Sudo","year":"2007","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.prp.2022.153831_bib4","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/hmg\/ddn153","article-title":"LAPSER1\/LZTS2: a pluripotent tumor suppressor linked to the inhibition of katanin-mediated microtubule severing","volume":"17","author":"Sudo","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"46","key":"10.1016\/j.prp.2022.153831_bib5","doi-asserted-by":"crossref","first-page":"40331","DOI":"10.1074\/jbc.M111.302059","article-title":"The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development","volume":"286","author":"Peng","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.prp.2022.153831_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0059-4","article-title":"Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma","volume":"50","author":"Hou","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.prp.2022.153831_bib7","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib8","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2022.153831_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","article-title":"A clearer view of the molecular complexity of clear cell renal cell carcinoma","volume":"10","author":"Frew","year":"2015","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2022.153831_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00345-010-0555-1","article-title":"Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention","volume":"28","author":"Weikert","year":"2010","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"issue":"269","key":"10.1016\/j.prp.2022.153831_bib12","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"6220","key":"10.1016\/j.prp.2022.153831_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.prp.2022.153831_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.prp.2022.153831_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41585-018-0052-7","article-title":"Epigenetic modifiers: activities in renal cell carcinoma","volume":"15","author":"de Cubas","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"7","key":"10.1016\/j.prp.2022.153831_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1541-7786.MCR-16-0115","article-title":"Insights into the genetic basis of the renal cell carcinomas from the cancer genome atlas","volume":"14","author":"Haake","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2022.153831_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.prp.2022.153831_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat. Genet."},{"issue":"21","key":"10.1016\/j.prp.2022.153831_bib19","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.prp.2022.153831_bib20","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1158\/1078-0432.CCR-17-2039","article-title":"Sarcomatoid renal cell carcinoma: The apple doesn\u2019t fall far from the tree","volume":"23","author":"Bergerot","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.prp.2022.153831_bib21","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.7150\/jca.27281","article-title":"Comprehensive analysis of BAP1 somatic mutation in clear cell renal cell carcinoma to explore potential mechanisms in silico","volume":"9","author":"Jin","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2022.153831_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fonc.2013.00277","article-title":"Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer","volume":"3","author":"Pihan","year":"2013","journal-title":"Front. Oncol."},{"issue":"7503","key":"10.1016\/j.prp.2022.153831_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature13277","article-title":"Oncogene-like induction of cellular invasion from centrosome amplification","volume":"510","author":"Godinho","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.153831_bib24","first-page":"167","article-title":"Centrosome \u2013 a promising anti-cancer target","volume":"10","author":"Rivera-Rivera","year":"2016","journal-title":"Biologics"},{"issue":"12","key":"10.1016\/j.prp.2022.153831_bib25","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-12-3886","article-title":"Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network","volume":"19","author":"Hakimi","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.prp.2022.153831_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-010-0599-y","article-title":"Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor","volume":"346","author":"Kim","year":"2011","journal-title":"Mol. Cell Biochem."},{"issue":"6","key":"10.1016\/j.prp.2022.153831_bib27","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1074\/jbc.M112.417568","article-title":"Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development","volume":"288","author":"Johnson","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2022.153831_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174357","article-title":"LZTS2 and PTEN collaboratively regulate ss-catenin in prostatic tumorigenesis","volume":"12","author":"Yu","year":"2017","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.prp.2022.153831_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as novel targets for renal cell carcinoma","volume":"19","author":"Brugarolas","year":"2013","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.1014","article-title":"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","volume":"44","author":"Guo","year":"2011","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.prp.2022.153831_bib31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1074\/jbc.R116.766782","article-title":"Reelin: Neurodevelopmental architect and homeostatic regulator of excitatory synapses","volume":"292","author":"Wasser","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prp.2022.153831_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031802","article-title":"Reelin is involved in transforming growth factor-beta1-induced cell migration in esophageal carcinoma cells","volume":"7","author":"Yuan","year":"2012","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41598-020-57534-5","article-title":"Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers","volume":"10","author":"Malouf","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2015.08.013","article-title":"Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma","volume":"369","author":"Peng","year":"2015","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.prp.2022.153831_bib35","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1158\/0008-5472.CAN-14-0221","article-title":"Deubiquitination of gamma-tubulin by BAP1 prevents chromosome instability in breast cancer cells","volume":"74","author":"Zarrizi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153831_bib36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/cup.14073","article-title":"BAP1-inactivated melanocytic tumors show prominent centrosome amplification and associated loss of primary cilia","volume":"48","author":"Ye","year":"2021","journal-title":"J. Cutan. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2022.153831_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcp\/aqaa176","article-title":"BAP1 \u2013 mutated clear cell renal cell carcinoma","volume":"155","author":"Gallan","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2022.153831_bib38","first-page":"1455","article-title":"BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma","volume":"10","author":"Xiao","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153831_bib39","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/ncomms6128","article-title":"Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/cbt.9.1.10451","article-title":"Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines","volume":"9","author":"Cho","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.prp.2022.153831_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1042\/BST20170087","article-title":"Regulation of the cell cycle and centrosome biology by deubiquitylases","volume":"45","author":"Darling","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.prp.2022.153831_bib42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1349-7006.2008.01075.x","article-title":"Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast","volume":"100","author":"Niu","year":"2009","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.prp.2022.153831_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.jnen.0000229235.20995.6e","article-title":"Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines","volume":"65","author":"Katsetos","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.prp.2022.153831_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jcp.22077","article-title":"Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines","volume":"223","author":"Caracciolo","year":"2010","journal-title":"J. Cell Physiol."},{"issue":"3","key":"10.1016\/j.prp.2022.153831_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006832","article-title":"Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome","volume":"15","author":"de Almeida","year":"2019","journal-title":"PLOS Comput. Biol."},{"issue":"7","key":"10.1016\/j.prp.2022.153831_bib46","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1083\/jcb.201710019","article-title":"Centrosome amplification disrupts renal development and causes cystogenesis","volume":"217","author":"Dionne","year":"2018","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.prp.2022.153831_bib47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.prp.2022.153831_bib48","first-page":"1499","article-title":"A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity","volume":"18","author":"Ji","year":"2007","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2022.153831_bib49","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12031-014-0230-x","article-title":"mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells","volume":"53","author":"Zhang","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.prp.2022.153831_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12957-018-1349-y","article-title":"LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma","volume":"16","author":"Shen","year":"2018","journal-title":"World J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2022.153831_bib51","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41388-020-01596-2","article-title":"beta-Trcp and CK1delta-mediated degradation of LZTS2 activates PI3K\/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma","volume":"40","author":"Lu","year":"2021","journal-title":"Oncogene"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:51:26Z","timestamp":1759733486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":51,"alternative-id":["S0344033822000747"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153831","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153831"}}